News Headlines Article

Pricey technology may drive growth in health spending, not economy or reform, analysis finds
Modern Healthcare

High-priced technology—not the economy and not healthcare reform—has the most potential to drive U.S. health spending growth upward in the years ahead, a new analysis published by the Brookings Institution has found. Economists at Harvard University and Dartmouth College said pricey brand-name drugs and capital-intensive technology are “the primary determinant of long-term growth.” They also said that despite sluggish spending on prescriptions in recent years, “there is little evidence of slowdowns in the technology pipeline.”